Prednisone is not recommended for osteoarthritis because it’s a powerful systemic anti-inflammatory drug being aimed at a condition that isn’t primarily driven by systemic inflammation. Osteoarthritis is caused by mechanical wear and tear on joints, not by an overactive immune system attacking them. That mismatch means you’d be absorbing all the serious side effects of a steroid without getting proportional relief, and long-term use can actually make the underlying joint damage worse.
Osteoarthritis Isn’t the Kind of Inflammation Steroids Target
Prednisone works by broadly suppressing the immune system and dialing down inflammation throughout the entire body. That makes it effective for autoimmune conditions like rheumatoid arthritis, where the immune system is actively attacking joint tissue and causing widespread, systemic inflammation. Osteoarthritis is a fundamentally different process. The joint damage comes from cartilage breaking down over time due to mechanical stress, aging, prior injury, or excess body weight. There is some localized inflammation in an osteoarthritic joint, but it’s a secondary consequence of the damage, not the driving force behind it.
Suppressing the whole immune system to address a localized, mechanical problem is like using a sledgehammer on a thumbtack. The drug reaches every organ in your body, but the problem is in one or two joints.
The Side Effects Hit Where OA Patients Are Already Vulnerable
Most people with osteoarthritis are middle-aged or older, and they commonly have other health conditions that prednisone makes worse. Long-term use leads to thinning bones (osteoporosis), poorly controlled diabetes, high blood pressure, and weight gain. These aren’t rare complications. They are expected outcomes of extended steroid use, and they overlap almost perfectly with the conditions that already affect the typical osteoarthritis population.
The American College of Rheumatology lists osteoporosis, diabetes, hypertension, cataracts, glaucoma, and a bone disorder called avascular necrosis among prednisone’s potential side effects. For someone whose bones and joints are already compromised, weakening them further with a steroid creates a net negative. Muscle weakness and low potassium levels can also develop, which undermine the physical activity that is one of the most effective treatments for OA in the first place.
Steroids Can Accelerate Cartilage Damage
Beyond failing to fix the problem, prednisone may actively worsen it. Glucocorticoids (the drug class that includes prednisone) impair cartilage metabolism and can increase joint and bone damage, particularly in arthritic joints. A review in Physiological Reviews noted that long-term steroid therapy is associated with impairment of cartilage growth and repair processes. Since the core issue in osteoarthritis is cartilage that’s already breaking down faster than it can rebuild, adding a drug that further tips that balance in the wrong direction is counterproductive.
Steroid Injections Are a Different Story
You may have heard that steroid injections are sometimes used for osteoarthritis, which can seem contradictory. The difference is delivery. An injection puts the corticosteroid directly into the affected joint, where it reduces local inflammation without flooding the rest of the body. The OARSI (Osteoarthritis Research Society International) guidelines list intra-articular corticosteroid injections as a recommended option for knee osteoarthritis, though not for hip or polyarticular OA.
Even injections have limits. They provide temporary relief, typically lasting weeks to a few months, and repeated injections over time may carry their own risks to cartilage. But the side effect profile is dramatically different from taking oral prednisone daily, because the drug stays mostly in the joint rather than circulating through your bloodstream, bones, and organs.
One small study did find that combining a short, low-dose course of oral steroids (15 mg for 14 days) with a single joint injection produced better pain and function scores than injection alone, with improvements lasting about 16 weeks. But this was a brief, carefully controlled course, not the kind of ongoing oral steroid use that causes the serious long-term complications.
What Works Better for Osteoarthritis
The treatments that major guidelines actually recommend for osteoarthritis target the problem more precisely. Oral and topical NSAIDs (nonsteroidal anti-inflammatory drugs, like ibuprofen or diclofenac gel) are strongly recommended as first-line options. They reduce pain and improve function with a narrower set of risks than systemic steroids, though they still need to be used carefully in people with cardiovascular disease or kidney problems.
Topical NSAIDs are particularly appealing for osteoarthritis because, like joint injections, they deliver anti-inflammatory relief closer to where it’s needed while minimizing what the rest of the body absorbs. For knee osteoarthritis especially, a topical gel applied directly to the joint can be as effective as an oral pill for many people, with far fewer gastrointestinal side effects.
Other options in the treatment toolkit include duloxetine (which works on pain signaling in the nervous system rather than inflammation), acetaminophen for mild symptoms, capsaicin cream, and hyaluronic acid injections. Exercise, weight management, and physical therapy remain the foundation of OA treatment across all guidelines, and they’re the only interventions that can actually slow the disease’s progression rather than just managing symptoms.
The Core Problem With Prednisone for OA
The case against prednisone for osteoarthritis comes down to a simple cost-benefit calculation. The benefits are modest because the drug doesn’t address the mechanical cause of the disease. The costs are steep: bone loss, blood sugar disruption, cardiovascular strain, weight gain, and potential acceleration of the cartilage damage you’re trying to treat. For a chronic condition that people live with for decades, those risks compound over time in ways that make the trade-off untenable. Treatments that target the joint directly, reduce pain through other mechanisms, or strengthen the structures around the joint all offer better long-term value with fewer systemic consequences.